ParaZero Technologies (PRZO) VP of R&D discloses option grant

Rhea-AI Filing Summary

ParaZero Technologies Ltd. filed an initial ownership report for Vice President of R&D Alon Yasovsky, showing a compensatory option position rather than any share purchase or sale. He holds options over 36,315 ordinary shares at an exercise price of 0.1414 per share, expiring on January 12, 2030.

As of this report, none of these options are vested or exercisable. According to the vesting schedule, 50% of the options will vest on December 1, 2027, and the remaining 50% will vest in eight equal quarterly installments thereafter, subject to his continued service. The filing notes that, to qualify for certain Israeli tax benefits under Section 102, securities issued under ParaZero’s 2022 Global Share Incentive Plan must be registered in the name of a trustee.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Yasovsky Alon

(Last) (First) (Middle)

C/O PARAZERO TECHNOLOGIES LTD.

1 HATACHANA STREET

(Street)

KFAR SABA 4453001

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ParaZero Technologies Ltd. [ PRZO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice President of R&D

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Ordinary Shares	(1)	01/12/2030	Ordinary Shares	36,315(2)	$0.1414	D

Explanation of Responses:

1. As of the date of this Form 3, 0 options to purchase ordinary shares are vested and currently exercisable. 50% shall vest on December 1, 2027 and the remaining 50% shall vest in 8 equal installments on a quarterly basis thereafter, subject to the Reporting Person's continued service.

2. To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the ParaZero Technologies Ltd. Global Share Incentive Plan (2022) must be registered in the name of a trustee.

	/s/ Alon Yasovsky	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What insider position does PRZO’s VP of R&D report on this Form 3?

ParaZero’s Vice President of R&D reports holding options over 36,315 ordinary shares. These are derivative securities, not currently exercisable, representing a compensation grant rather than an open-market transaction or direct share ownership at this time.

Are any of Alon Yasovsky’s PRZO options currently vested or exercisable?

None of the reported options are vested or exercisable as of this Form 3. The entire 36,315-option grant remains unvested and will begin vesting in the future according to the specified schedule tied to continued employment.

What is the vesting schedule for the PRZO options held by the VP of R&D?

Half of the options will vest on December 1, 2027, with the remaining half vesting in eight equal quarterly installments. This schedule is contingent on the reporting person’s continued service with ParaZero, spreading vesting over several years.

What are the key terms of the PRZO option grant disclosed on this Form 3?

The option grant covers 36,315 underlying ordinary shares at an exercise price of 0.1414 per share, expiring on January 12, 2030. It currently has zero vested options and features a back-weighted vesting schedule starting in late 2027.

How does Israeli tax law affect the PRZO options reported in this filing?

To qualify for tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued under ParaZero’s 2022 Global Share Incentive Plan must be registered in a trustee’s name. This structural requirement supports favorable tax treatment for employee equity awards.

Does this PRZO Form 3 indicate any insider buying or selling in the market?

The Form 3 does not report any market purchases or sales of ParaZero shares. It simply establishes an initial statement of beneficial ownership for an unvested stock option grant held by the Vice President of R&D.